The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mycoplasma Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
The global Mycoplasma Diagnostics market size is expected to reach US$ 998.5 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Mycoplasma Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Clinics and Others, are propelling Mycoplasma Diagnostics market. Kits & Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycoplasma Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycoplasma Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycoplasma Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycoplasma Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycoplasma Diagnostics covered in this report include Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics and Tecan Trading (Tecan Group), etc.
The global Mycoplasma Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Global Mycoplasma Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycoplasma Diagnostics market, Segment by Type:
Kits & Reagents
Instruments
Software & Services
Global Mycoplasma Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycoplasma Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
The global Mycoplasma Diagnostics market size is expected to reach US$ 998.5 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Mycoplasma Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Clinics and Others, are propelling Mycoplasma Diagnostics market. Kits & Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycoplasma Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycoplasma Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycoplasma Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycoplasma Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycoplasma Diagnostics covered in this report include Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics and Tecan Trading (Tecan Group), etc.
The global Mycoplasma Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Global Mycoplasma Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycoplasma Diagnostics market, Segment by Type:
Kits & Reagents
Instruments
Software & Services
Global Mycoplasma Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycoplasma Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Mycoplasma Diagnostics
1.1 Mycoplasma Diagnostics Market Overview
1.1.1 Mycoplasma Diagnostics Product Scope
1.1.2 Mycoplasma Diagnostics Market Status and Outlook
1.2 Global Mycoplasma Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mycoplasma Diagnostics Market Size by Region (2018-2029)
1.4 Global Mycoplasma Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Mycoplasma Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mycoplasma Diagnostics Market Size (2018-2029)
1.6.1 North America Mycoplasma Diagnostics Market Size (2018-2029)
1.6.2 Europe Mycoplasma Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Mycoplasma Diagnostics Market Size (2018-2029)
1.6.4 Latin America Mycoplasma Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Mycoplasma Diagnostics Market Size (2018-2029)
2 Mycoplasma Diagnostics Market by Type
2.1 Introduction
2.1.1 Kits & Reagents
2.1.2 Instruments
2.1.3 Software & Services
2.2 Global Mycoplasma Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mycoplasma Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mycoplasma Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mycoplasma Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mycoplasma Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mycoplasma Diagnostics Revenue Breakdown by Type (2018-2029)
3 Mycoplasma Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Clinics
3.1.4 Others
3.2 Global Mycoplasma Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mycoplasma Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mycoplasma Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mycoplasma Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mycoplasma Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mycoplasma Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mycoplasma Diagnostics Revenue Breakdown by Application (2018-2029)
4 Mycoplasma Diagnostics Competition Analysis by Players
4.1 Global Mycoplasma Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mycoplasma Diagnostics as of 2022)
4.3 Date of Key Players Enter into Mycoplasma Diagnostics Market
4.4 Global Top Players Mycoplasma Diagnostics Headquarters and Area Served
4.5 Key Players Mycoplasma Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Mycoplasma Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies Mycoplasma Diagnostics Products, Services and Solutions
5.1.4 Agilent Technologies Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 PromoCell
5.3.1 PromoCell Profile
5.3.2 PromoCell Main Business
5.3.3 PromoCell Mycoplasma Diagnostics Products, Services and Solutions
5.3.4 PromoCell Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Charles River Laboratories International Recent Developments
5.4 Charles River Laboratories International
5.4.1 Charles River Laboratories International Profile
5.4.2 Charles River Laboratories International Main Business
5.4.3 Charles River Laboratories International Mycoplasma Diagnostics Products, Services and Solutions
5.4.4 Charles River Laboratories International Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Charles River Laboratories International Recent Developments
5.5 Merck KGaA
5.5.1 Merck KGaA Profile
5.5.2 Merck KGaA Main Business
5.5.3 Merck KGaA Mycoplasma Diagnostics Products, Services and Solutions
5.5.4 Merck KGaA Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck KGaA Recent Developments
5.6 Lonza Group
5.6.1 Lonza Group Profile
5.6.2 Lonza Group Main Business
5.6.3 Lonza Group Mycoplasma Diagnostics Products, Services and Solutions
5.6.4 Lonza Group Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Group Recent Developments
5.7 Takara Bio (Takara Holding Company.)
5.7.1 Takara Bio (Takara Holding Company.) Profile
5.7.2 Takara Bio (Takara Holding Company.) Main Business
5.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Products, Services and Solutions
5.7.4 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio (Takara Holding Company.) Recent Developments
5.8 Savyon Diagnostics
5.8.1 Savyon Diagnostics Profile
5.8.2 Savyon Diagnostics Main Business
5.8.3 Savyon Diagnostics Mycoplasma Diagnostics Products, Services and Solutions
5.8.4 Savyon Diagnostics Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Savyon Diagnostics Recent Developments
5.9 Tecan Trading (Tecan Group)
5.9.1 Tecan Trading (Tecan Group) Profile
5.9.2 Tecan Trading (Tecan Group) Main Business
5.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Products, Services and Solutions
5.9.4 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Tecan Trading (Tecan Group) Recent Developments
5.10 Sartorius Stedim BioOutsource
5.10.1 Sartorius Stedim BioOutsource Profile
5.10.2 Sartorius Stedim BioOutsource Main Business
5.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Products, Services and Solutions
5.10.4 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Sartorius Stedim BioOutsource Recent Developments
5.11 American Type Culture Collection (ATCC)
5.11.1 American Type Culture Collection (ATCC) Profile
5.11.2 American Type Culture Collection (ATCC) Main Business
5.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Products, Services and Solutions
5.11.4 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 American Type Culture Collection (ATCC) Recent Developments
5.12 F Hoffmann-La Roche
5.12.1 F Hoffmann-La Roche Profile
5.12.2 F Hoffmann-La Roche Main Business
5.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Products, Services and Solutions
5.12.4 F Hoffmann-La Roche Mycoplasma Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 F Hoffmann-La Roche Recent Developments
6 North America
6.1 North America Mycoplasma Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Mycoplasma Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mycoplasma Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mycoplasma Diagnostics Market Dynamics
11.1 Mycoplasma Diagnostics Industry Trends
11.2 Mycoplasma Diagnostics Market Drivers
11.3 Mycoplasma Diagnostics Market Challenges
11.4 Mycoplasma Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
